Department of Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, Canada.
Am J Cardiol. 2011 Oct 1;108(7):1008-13. doi: 10.1016/j.amjcard.2011.05.035. Epub 2011 Jul 27.
In most patients with aortic regurgitation (AR), aortic valve replacement (AVR) results in favorable left ventricular (LV) remodeling and normalization of the LV ejection fraction (EF). However, some patients with severe AR will not have favorable remodeling and their LVEF will not normalize. The goal of the present study was to determine whether remodeling and clinical outcomes after AVR could be predicted from simple preoperative echocardiographic analysis. A total of 56 consecutive patients with chronic severe pure AR who underwent AVR had preoperative (5 ± 2 days), early postoperative (5 ± 2 days), and late postoperative (328 ± 88 days) echocardiographic data retrospectively analyzed. The LV diameter, The LVEF and stroke volume (SV) were measured. The reduction in LV end-diastolic dimension decreased by 14% (from 65 ± 6 mm to 56 ± 8 mm, p <0.001) early after AVR, with an additional reduction of only 6% late after AVR. More than 2/3 of the overall reduction in end-diastolic dimension was observed the week after AVR. Forty-six patients (82%) had positive early LV remodeling, defined as a 10% reduction in the LV end-diastolic diameter 1 week after AVR. All patients with early LV remodeling had a preoperative SV of ≥97 ml, which was the best predictor of late postoperative LVEF of ≥45% (sensitivity 98% and specificity 100%). Patients with a preoperative SV of ≥97 ml had a markedly greater event-free survival rate (92% vs 13%, p <0.001) at 3 years. In conclusion, in patients undergoing AVR for chronic severe pure AR, preoperative SV is the best predictor of LV remodeling and outcomes.
在大多数主动脉瓣反流(AR)患者中,主动脉瓣置换(AVR)可导致左心室(LV)重塑和 LV 射血分数(EF)正常化。然而,一些严重 AR 患者不会出现有利的重塑,其 LVEF 也不会正常化。本研究旨在确定是否可以从简单的术前超声心动图分析中预测 AVR 后的重塑和临床结果。回顾性分析了 56 例连续慢性重度单纯 AR 患者的术前(5±2 天)、术后早期(5±2 天)和术后晚期(328±88 天)的超声心动图数据。测量 LV 直径、LVEF 和每搏量(SV)。LV 舒张末期直径减少 14%(从 65±6mm 减少到 56±8mm,p<0.001),AVR 后早期仅再减少 6%。超过 2/3 的舒张末期直径总减少发生在 AVR 后一周内。46 例(82%)患者出现早期 LV 重塑,定义为 AVR 后 1 周 LV 舒张末期直径减少 10%。所有早期 LV 重塑的患者术前 SV 均≥97ml,这是预测晚期术后 LVEF≥45%的最佳指标(敏感性 98%,特异性 100%)。术前 SV≥97ml 的患者在 3 年时无事件生存率(92%对 13%,p<0.001)显著更高。总之,在接受慢性重度单纯 AR 行 AVR 的患者中,术前 SV 是 LV 重塑和结果的最佳预测指标。